Centene EBITDA 2010-2024 | CNC

Centene EBITDA for the quarter ending September 30, 2024 was $0.978B, a 8% decline year-over-year.

  • Centene 2023 EBITDA was 4.223B, a 53.68% increase from 2022.
  • Centene 2022 EBITDA was 2.748B, a 11.89% decline from 2021.
  • Centene 2021 EBITDA was 3.119B, a 28.15% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Centene EBITDA 2010-2024 | CNC

  • Centene 2023 EBITDA was 4.223B, a 53.68% increase from 2022.
  • Centene 2022 EBITDA was 2.748B, a 11.89% decline from 2021.
  • Centene 2021 EBITDA was 3.119B, a 28.15% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
UnitedHealth Group (UNH)$566.7B
Cigna Group (CI)$88.9B
Humana (HUM)$34.7B
Molina Healthcare (MOH)$18.9B
Select Medical Holdings (SEM)$5.1B
Joint (JYNT)$174M
Aethlon Medical (AEMD)$6M